Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00135668 · ClinicalTrials.gov registry record · Phase 2
Dose-response Study of Sodium Nitroprusside in Children Requiring Controlled Hypotension in the Operating Room
A Phase 2 study, sponsored by The Emmes Company.
- Completed
- Registry status
- Phase 2
- Development phase
- 211
- Enrollment target
NCT00135668: Completed Phase 2 study, sponsored by The Emmes Company.
NCT00135668 is a Phase 2 study that has completed, run by The Emmes Company. The registered enrollment target is 211 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (59% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00135668, a Phase 2 study, has completed, sponsored by The Emmes Company.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 211 participants
- Enrollment target
Study Summary
Sodium nitroprusside (SNP) has been approved for control of blood pressure in adults, yet there are no controlled studies in children. The purpose of this study is to determine the efficacy and safety of sodium nitroprusside in children who will be having surgery, and who require blood pressure lowering in order to decrease the amount of blood loss during their surgery.
Primary Outcome
From the Baseline MAP until the end of the blinded phase; scheduled for 30 min
Interventions
- DRUG Nitroprusside
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 211 participants |
| Start Date | 2005-08 |
| Est. Completion | 2009-02 |
| Phase | Phase 2 |
What the finished NCT00135668 record still lists
NCT00135668 is an interventional study that assigns participants to a tested intervention. The registered 211 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (59% higher).
The record links to 0 conditions, and to 1 intervention - of which Nitroprusside is the first listed.
NCT00135668 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00135668 about?
NCT00135668 is a clinical study titled "Dose-response Study of Sodium Nitroprusside in Children Requiring Controlled Hypotension in the Operating Room". Sodium nitroprusside (SNP) has been approved for control of blood pressure in adults, yet there are no controlled studies in children. The purpose of this study is to determine the efficacy and safety of sodium nitroprusside in children who will be having surgery, and who require blood pressure lowe...
What is the current status of trial NCT00135668?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 211 participants. The study started on 2005-08. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00135668?
The interventions under investigation include: Nitroprusside (DRUG).
Who is sponsoring clinical trial NCT00135668?
This trial is sponsored by The Emmes Company, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00135668's enrollment target sits among peer trials
211 290th of 2000 higher than 1,711 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06698796 · 211 participants · Phase 3
A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies
- NCT04228978 · 212 participants · NA
Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss
- NCT04725721 · 212 participants · NA
Testing FIRST in Youth Outpatient Psychotherapy
- NCT06257576 · 212 participants · Phase 3
Function of Tamsulosin in Older Males Undergoing Surgery with Indwelling Catheter
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia